The blood-brain barrier limits the therapeutic efficacy of antibody-drug conjugates in glioblastoma
Author(s) -
Roger Abounader,
David Schiff
Publication year - 2021
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noab223
Subject(s) - glioblastoma , blood–brain barrier , drug , antibody drug conjugate , antibody , medicine , conjugate , pharmacology , cancer research , monoclonal antibody , immunology , central nervous system , mathematical analysis , mathematics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom